No argument, it is a long haul no doubt about it.
But Imugene is at a critical juncture in terms of the science, they can't avoid the results from the Her-Vaxx trial. The alarm bell for me went off(for a number of reasons) when right at the moment they should be updating trial results on Her-Vaxx we are suddenly plunged into the takeover of the Mayo clinic.
I would like an update on what is happening with Her-Vaxx, we are getting Nada.
Having said that, I still trust the management and they do have a great track record.
That is all we have people. Anyone for two-up?
IMU - The Value Proposition, page-173
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.001(1.79%) |
Mkt cap ! $418.9M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.7¢ | 5.4¢ | $461.9K | 8.347M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1082545 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 603058 | 6 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |